EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Binding free energy analysis of galectin‐3 natural ligands and synthetic inhibitors

Luke Newman, Valerie Vaissier Welborn iD

Protein Science · 2025

DOI: 10.1002/pro.70143 ↗

At a glance

Journal article in Protein Science, 2025. Written by Luke Newman and 1 co-authors. Institution: Department of Chemistry, Virginia Tech, Blacksburg, Virginia, USA. Major MEDLINE topics: Galectin 3. Cited 1 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Science Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Galectin‐3–ligand complexes are characterized by halogen, σ‐hole bonds, hydrogen bonds, cation‐π and CH‐π interactions. Here, we model these non‐covalent interactions with the AMOEBA polarizable force field and conduct an absolute binding free energy analysis on leading galectin‐3 inhibitors. Synthetic drug molecules GB0139, GB1107, and GB1211 were estimated to have binding free energies of −4.3, −6.7, and −9.5 kcal/mol respectively. This compares to −0.3 and 1.4 kcal/mol for the natural ligands, N‐acetyllactosamine type 1 and type 2, respectively. We calculated the electric fields projected along key bonds in each ligand to further rationalize these results. We find that while the hydroxyl groups of the natural ligands interact reasonably well with residues in galectin‐3's binding pocket, structural dynamics weaken the binding pose and favor interactions with water, sometimes yielding to dissociation. In contrast, the more favorable binding energy of GB1211, leading inhibitor in clinical studies, is associated with strong and constant electric fields across the bonds investigated, suggesting a stiffer binding pose with a stabilizing σ‐hole interaction.

Subjects

MeSH terms (MEDLINE)

Galectin 3LigandsThermodynamicsHumansProtein BindingHydrogen BondingBinding SitesBlood ProteinsGalectins

Author keywords

AMOEBAalchemicalbinding free energygalectingalectin‐3inhibitorligandmolecular dynamics

Substances

LigandsGalectin 3LGALS3 protein, humanBlood ProteinsGalectins

Authors and institutions

  • Department of Chemistry, Virginia Tech, Blacksburg, Virginia, USA.
  • Macromolecules Innovation Institute, Virginia Tech, Blacksburg, Virginia, USA.

ORCID profiles: Valerie Vaissier Welborn

Funding

  • National Science Foundation

Cite

APA

Newman, L., & Vaissier Welborn, V. (2025). Binding free energy analysis of galectin‐3 natural ligands and synthetic inhibitors. Protein Science. https://doi.org/10.1002/pro.70143

Vancouver

Newman L, Vaissier Welborn V. Binding free energy analysis of galectin‐3 natural ligands and synthetic inhibitors. Protein Science. 2025. doi:10.1002/pro.70143

BibTeX
@article{Newman2025,
  author = {Newman, Luke and Vaissier Welborn, Valerie},
  title = {Binding free energy analysis of galectin‐3 natural ligands and synthetic inhibitors},
  journal = {Protein Science},
  year = {2025},
  doi = {10.1002/pro.70143}
}
Start for free →